Cargando…
Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models
Glycosylation is one of the most common protein modifications in living organisms and has important regulatory roles in animal tissue development and homeostasis. Here, we present a protocol for generation of 3D organotypic skin models using CRISPR-Cas9 genetically engineered human keratinocytes (N/...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403582/ https://www.ncbi.nlm.nih.gov/pubmed/34485933 http://dx.doi.org/10.1016/j.xpro.2021.100668 |
_version_ | 1783746029742456832 |
---|---|
author | Marinova, Irina N. Wandall, Hans H. Dabelsteen, Sally |
author_facet | Marinova, Irina N. Wandall, Hans H. Dabelsteen, Sally |
author_sort | Marinova, Irina N. |
collection | PubMed |
description | Glycosylation is one of the most common protein modifications in living organisms and has important regulatory roles in animal tissue development and homeostasis. Here, we present a protocol for generation of 3D organotypic skin models using CRISPR-Cas9 genetically engineered human keratinocytes (N/TERT-1) to study the role of glycans in epithelial tissue formation. This strategy is also applicable to other gene targets and organotypic tissue models. Careful handling of the cell cultures is critical for the successful formation of the organoids. For complete details on the use and execution of this protocol, please refer to Dabelsteen et al. (2020). |
format | Online Article Text |
id | pubmed-8403582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84035822021-09-02 Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models Marinova, Irina N. Wandall, Hans H. Dabelsteen, Sally STAR Protoc Protocol Glycosylation is one of the most common protein modifications in living organisms and has important regulatory roles in animal tissue development and homeostasis. Here, we present a protocol for generation of 3D organotypic skin models using CRISPR-Cas9 genetically engineered human keratinocytes (N/TERT-1) to study the role of glycans in epithelial tissue formation. This strategy is also applicable to other gene targets and organotypic tissue models. Careful handling of the cell cultures is critical for the successful formation of the organoids. For complete details on the use and execution of this protocol, please refer to Dabelsteen et al. (2020). Elsevier 2021-07-10 /pmc/articles/PMC8403582/ /pubmed/34485933 http://dx.doi.org/10.1016/j.xpro.2021.100668 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Protocol Marinova, Irina N. Wandall, Hans H. Dabelsteen, Sally Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models |
title | Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models |
title_full | Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models |
title_fullStr | Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models |
title_full_unstemmed | Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models |
title_short | Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models |
title_sort | protocol for crispr-cas9 modification of glycosylation in 3d organotypic skin models |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403582/ https://www.ncbi.nlm.nih.gov/pubmed/34485933 http://dx.doi.org/10.1016/j.xpro.2021.100668 |
work_keys_str_mv | AT marinovairinan protocolforcrisprcas9modificationofglycosylationin3dorganotypicskinmodels AT wandallhansh protocolforcrisprcas9modificationofglycosylationin3dorganotypicskinmodels AT dabelsteensally protocolforcrisprcas9modificationofglycosylationin3dorganotypicskinmodels |